AU628598B2 - Process for producing l-glutamic acid - Google Patents
Process for producing l-glutamic acid Download PDFInfo
- Publication number
- AU628598B2 AU628598B2 AU58745/90A AU5874590A AU628598B2 AU 628598 B2 AU628598 B2 AU 628598B2 AU 58745/90 A AU58745/90 A AU 58745/90A AU 5874590 A AU5874590 A AU 5874590A AU 628598 B2 AU628598 B2 AU 628598B2
- Authority
- AU
- Australia
- Prior art keywords
- glutamic acid
- brevibacterium
- producing
- microorganism
- ferm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 title claims description 50
- 229960002989 glutamic acid Drugs 0.000 title claims description 24
- 238000000034 method Methods 0.000 title claims description 15
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 11
- 244000005700 microbiome Species 0.000 claims description 11
- BWDOCCNJZQOHQF-GYENTSQJSA-N (2r)-2-amino-n-(4-amino-1,3-dihydroxy-5-oxopentan-2-yl)propanamide;hydrochloride Chemical compound [Cl-].C[C@@H]([NH3+])C(=O)NC(CO)C(O)C(N)C=O BWDOCCNJZQOHQF-GYENTSQJSA-N 0.000 claims description 10
- XZCFXWQEALCPOV-UHFFFAOYSA-N Prumyciin Natural products CC(N)C(=O)NC1COC(O)C(N)C1O XZCFXWQEALCPOV-UHFFFAOYSA-N 0.000 claims description 10
- WNHRQLPCWMCOQE-UHFFFAOYSA-N Prumycin Natural products CC(N)C(=O)NCC1OC(O)C(N)C1O WNHRQLPCWMCOQE-UHFFFAOYSA-N 0.000 claims description 10
- 241000186146 Brevibacterium Species 0.000 claims description 9
- 241000186216 Corynebacterium Species 0.000 claims description 6
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 claims description 4
- 241000807905 Corynebacterium glutamicum ATCC 14067 Species 0.000 claims description 2
- 241000319304 [Brevibacterium] flavum Species 0.000 claims description 2
- 230000003505 mutagenic effect Effects 0.000 claims description 2
- 231100000219 mutagenic Toxicity 0.000 claims 1
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZXFLCMHBSA-N 5-[(3ar,4r,6as)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid Chemical compound N1C(=O)N[C@H]2[C@@H](CCCCC(=O)O)SC[C@H]21 YBJHBAHKTGYVGT-ZXFLCMHBSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- BQQVEASFNMRTBA-UHFFFAOYSA-N 2-[4-(3-aminopropyl)piperazin-1-yl]ethanol Chemical compound NCCCN1CCN(CCO)CC1 BQQVEASFNMRTBA-UHFFFAOYSA-N 0.000 description 1
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 229930195714 L-glutamate Natural products 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- GUAFOGOEJLSQBT-UHFFFAOYSA-N aesculetin dimethyl ether Natural products C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/14—Glutamic acid; Glutamine
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
6285q8
AUSTRALIA
PATENTS ACT 1952 COMPLETE SPECIFICATION Form
(ORIGINAL)
FOR OFFICE USE Short Title: Int. Cl: Application Number: Lodged: t a t Complete Specification-Lodged: Accepted: Lapsed: Published: Priority: Related Art: TO BE COMPLETED BY APPLICANT Name of Applicant: Address of Applicant: Actual Inventor: Actual Inventor: AJINOMOTO CO., INC.
NO 5-8 KYOBASHI 1 CHOME
CHUO-KU
TOKYO
JAPAN
GRIFFITH HACK CO., 601 St. Kilda Road, Melbourne, Victoria 3004, Australia.
Address for Service: Complete Specification for the invention entitled: PROCESS FOR PRODUCING L-GLUTAMIC ACID.
The following statement is a full description of this invention including the best method of performing it known to me:- -2 PROCESS FOR PRODUCING L-GLUTAMIC ACID This invention relates to a process for producing L-glutamic acid and especially to a process which comprises growing a microorganism belonging to the genus Brevibacterium or the genus Corynebacterium, resistant to prumycin and derivatives thereof, and capable of producing L-glutamic acid; and recovering L-glutamic acid formed and accumulated in the culture liquor. The invention also relates to novel microorganisms which are useful in this process.
DETAILED DESCRIPTION OF THE INVENTION (Technical Field) L-glutamic acid is an important amino acid useful as a seasoning and for other purposes. This invention provides an improved fermentation process for producing this amino acid.
9 t (Prior Art) Already known are the fermentation methods for producing L-glutamic acid, which employ a wild strain of Brevibacterium or Corynebacterium, a strain resistant to glutamic acid analogues, a strain resistant to respiratory inhibitors, such as keto-malonic acid and fluoroacetic acid, or a strain resistant to esculetin.
(Problem to be Solved by the Invention) The object of this invention is to enhance the I fermentation yield of L-glutamic acid, thereby reducing its production cost.
(Means to Solve the Problem) Studies to solve the above-mentioned problem have led us to find that L-glutamic acid can be produced with a higher yield by the use of mutants resistant to prumycin and derivatives thereof and derived from the already known, L-glutamate-producing microorganisms Brevibacterium and Corynebacterium. Prumycin is an antibiotic produced by microorganisms belonging to the genus Bacillus.
3 Listed below are some examples of the strains of Brevibacterium and Corynebacterium resistant to prumycin and derivatives thereof used in this invention.
Brevibacterium lactofermentum AJ 12475(FERM P-10827, FERM BP-2922) Brevibacterium lactofermentum AJ 12476(FERM P-10828, FERM BP-2923) Brevibacterium flavum AJ 12477(FERM P-10829, FERM BP-2924) Corynebacterium glutamicum AJ 12478(FERM P-10830, FERM BP-2925) o Deposits of these strains under the Budapest Treaty were lodged in the Fermentation Research Institute of the Agency o o lo \c' S0 for Industrial Science and Technology onAi-ts MsSS, under the above-mentioned accession numbers.
SThese strains have been derived from Brevibacterium lactofermentum ATCC 13869, Brevibacterium flavum ATCC 14067 and Corynebacterium glutamicum ATCC 13032, respectively, by mutation. All of the starting strains were available to the public before 19th July 1989.
0eo0 0 The mutation may be effected by ordinary methods, such s o as irradiation with ultraviolet rays or X-rays, or by treatment with a mutagen (for example, treatment with 200 pg/ml nitrosoguanidine at 0°C for 20 minutes).
'Table 1 shows the experimental result on the prumycin resistance of these strains.
1 j X I lli ~plr irrrwur~-- la~QPI'IL-~Y 4- Table 1 0 er t000 Brevibacterium Brevibacterium Corynebacterium lactofermentum flavum glutamicum prumycin (mg/ml) ATCC AJ AJ ATCC AJ ATCC AJ 13869 12475 12476 14067 12477 13032 12478 0 100 100 100 100 100 100 100 2 51 115 110 40 100 53 105 3 23 110 110 0 98 2 99 4 8 105 104 0 88 0 6 100 90 0 70 0 1j *i '0 L-glutamic acid is produced by using these strains as ,i described below. Cultivation is carried out by using a liquid medium containing saccharic materials (such as sugar juice or waste molasses of sugar canes or beets, and starch hydrolyzates) and non-saccharic materials (such as acetic S°o acid, ethanol and paraffin). Nitrogen sources which may be o used include ammonium salts, ammonia water and urea (compounds used in ordinary L-glutamic acid fermentation), as °0 well as CSL and amino acids obtained by protein degradation.
In addition, inorganic salts (such as phosphates and magnesium salts) and trace nutrients (such as thiamin and biotin) may also be used as required. Furthermore, inhibitory substances against the action of biotin (such as polyoxysorbitan monopalmitate and penicillin) may also be added to the medium when required. Cultivation should preferably be carried out under aerobic conditions at a temperature of 240 to 370C while maintaining the pH within the range from 6 to 9 by the use of an inorganic or organic acid or base, urea, calcium carbonate or ammonia gas.
L-glutamic acid accumulated in the fermentation liquor can be recovered by an appropriate combination of ion-exchange resin treatment and other known techniques.
i;; 5 The growth of the strains listed in Table 1 was examined according to the procedure described below. Each strain was slant cultured in natural medium (containing 1 g/dl peptone, 1 g/dl yeast extract and 0.5 g/dl NaC1; pH for 24 hours, a suspension of the grown cells in sterile water was inoculated to a medium containing 0.5 g/dl glucose, 0.15 g/dl urea, 0.15 g/dl ammonium sulfate, 0.3 g/dl KH 2 P0 4 0.1 g/dl K 2 HP0 4 0.01 g/dl MgSO 4 .7H 2 0, 0.1 mg/dl CaC1 2 .2H 2 0, pg/dl thiamin hydrochloride, 3 pg/dl biotin, 0.44 mg/dl Na 2
B
4 07.10H 2 0, 4.85 mg/dl FeC1 2 .6H 2 0, 1.95 mg/dl CuSO 4 .5H 2 0, 0.185 mg/dl (NH 4 2 Mo70 24 .4H 2 0, 44 mg/dl ZnSO 4 .7H 2 0, 0.36 mg/dl MnCl 2 .4H 2 0, and prumycin in an amount shown in the a" table (pH and cultivation was continued for 24 hours.
0o o 0 0 S EXAMPLE 4o e 9 Example 1 A culture medium containing 10 g/dl glucose, 0.1 g/dl
KH
2
PO
4 0.1 g/dl MgSO 4 .7H 2 0, 20 pg/dl thiamin hydrochloride, 36 mg/dl concentrate of bean degradation solution, 2.0 g/dl ammonium sulfate, 1 mg/dl FeSO 4 .7 2 0, 1 mg/dl MnSO 4 .4H 2 0 and 3 ug/dl biotin (pH 7.0) was prepared, and 20 ml of the medium thus obtained was placed in each of 500-ml shake flasks and sterilized by heating at 115 0 C for 0 0 ten minutes. Each of the strains was inoculated into the sterilized medium and grown at 31.5 0 C by using a reciprocating shake culture machine.
The pH of the culture liquor was maintained within the S0', range from 6.5 to 8.0 by addition of 5 g/dl calcium carbonate; 2.5 g/dl ammonium sulfate was added after 24 hours, fermentation was terminated after 46 hours, and the yield of L-glutamic acid accumulated was measured.
The result obtained is summarized in Table 2.
L
6 Table 2 Total Yield of L-Glutamic Acid Brevibacterium lactofermentum ATCC 13869 48 AJ 12475 54 AJ 12476 51 Corynebacterium glutamicum ATCC 13032 45 AJ 12478 48 00 00 0 000 0 0090 09 0 00 0 0 90 0 00 0 00 5 Example 2 A culture medium containing 100 mg/ml beet molasses (as reducing sugar) and 1 mg/dl KH 2
PO
4 (pH 7.0) was prepared, and 30 ml of the medium thus obtained was placed in each of 500-mi shake flasks and sterilized by heating at 115°C for ten minutes. Each of the strains was inoculated into the sterilized medium and grown at 31.5°C by using a reciprocating shake culture machine, and the pH of the culture liquor was maintained within the range from 6.5 to by addition of 400 mg/dl aqueous solution of urea.
Polyoxysorbitan monopalmitate was added to a concentration of 4 mg/ml when the cells were grown to a predetermined level and fermentation was terminated 30 hours after inoculation, and the yield of L-glutamic acid accumulated was measured.
The result obtained is summarized in Table 3.
I I -7 Table 3 Total Yield of L-Glutamic Acid Brevibacterium lactofermentum ATCC 13869 57 AJ 12475 61 AJ 12476 62 Brevibacterium. flavum ATCC 14067 56 AJ 12477 60 Corynebacterium glutamicum ATCC 13032 53 AJ 12478 58 o 6 4. d* 00 0 -0 0 It will be clearly understood that the invention in its general aspects is not limited to the specific details ref erred to hereinabove.
Claims (7)
1. A microorganism which is capable of producing L- glutamic acid and which is resistant to prumycin and derivatives thereof, produced by the step of subjecting an initially L-glutamic acid-producing microorganism of the genus Brevibacterium or of the genus Corynebacterium to a mutagenic stimulus, and selecting mutants which are resistant to prumycin or a derivative thereof. s o a S 10
2. A microorganism according to Claim 1, wherein the S°"initially L-glutamic acid-producing microorganism is selected from the group consisting of Brevibacterium o. lactofermentum ATCC 13869, Brevibacterium flavum ATCC 14067, and Corynebacterium glutamicum ATCC 13032. 15
3. A microorganism according to Claim 1 or Claim 2, selected from the group consisting of Brevibacterium lactofermentum FERM BP-2922, S" Brevibacterium lactofermentum FERM BP-2922 Brevibacterium lactofermentum FERM BP-2923 0:00 •Brevibacterium flavum FERM BP-2924, and Corynebacterium glutamicum FERM BP-2925, as hereinbefore described.
4. A process for producing L-glutamic acid, comprising the steps of growing a microorganism of the genus Brevibacterium of the genus Corynebacterium which is resistant to prumycin and derivatives thereof, and which is capable of producing L-glutamic acid, and recovering L- glutamic acid from the culture liquor.
5. A process according to Claim 4, in which the microorganism is as defined in any one of Claims 1 to 3. i -r j- Eurerc~---I~~U~ 9
6. L-glutamic acid produced by the process of Claim 4 or Claim
7. A process substantially as hereinbefore described with reference to the examples. DATED THIS 30TH DAY OF JUNE 1992 AJINOMOTO CO., INC. 10 By Its Patent Attorneys: o GRIFFITH HACK CO SFellows Institute of Patent S 15 Attorneys of Australia a 0 o e e os o 0 0 0 LL
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1-186282 | 1989-07-19 | ||
| JP1186282A JP2817228B2 (en) | 1989-07-19 | 1989-07-19 | Method for producing L-glutamic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU5874590A AU5874590A (en) | 1991-03-28 |
| AU628598B2 true AU628598B2 (en) | 1992-09-17 |
Family
ID=16185579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU58745/90A Ceased AU628598B2 (en) | 1989-07-19 | 1990-07-06 | Process for producing l-glutamic acid |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JP2817228B2 (en) |
| KR (1) | KR970009156B1 (en) |
| AU (1) | AU628598B2 (en) |
| BR (1) | BR9003459A (en) |
| FR (1) | FR2649993B1 (en) |
| MY (1) | MY105945A (en) |
| PE (1) | PE33790A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110923275B (en) * | 2019-12-24 | 2024-01-12 | 内蒙古阜丰生物科技有限公司 | Glutamic acid fermentation and extraction process |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3096252A (en) * | 1960-04-23 | 1963-07-02 | Ajinomoto Kk | Process for producing l-glutamic acid |
| AU2257767A (en) * | 1966-06-17 | 1968-12-05 | Kyowa Hakko Kogyo Co. Ltd | Process for producing l glutamic acid |
-
1989
- 1989-07-19 JP JP1186282A patent/JP2817228B2/en not_active Expired - Lifetime
-
1990
- 1990-07-06 AU AU58745/90A patent/AU628598B2/en not_active Ceased
- 1990-07-16 KR KR1019900010782A patent/KR970009156B1/en not_active Expired - Fee Related
- 1990-07-17 BR BR909003459A patent/BR9003459A/en not_active Application Discontinuation
- 1990-07-17 PE PE1990172305A patent/PE33790A1/en not_active IP Right Cessation
- 1990-07-17 MY MYPI90001193A patent/MY105945A/en unknown
- 1990-07-19 FR FR9009249A patent/FR2649993B1/en not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3096252A (en) * | 1960-04-23 | 1963-07-02 | Ajinomoto Kk | Process for producing l-glutamic acid |
| AU2257767A (en) * | 1966-06-17 | 1968-12-05 | Kyowa Hakko Kogyo Co. Ltd | Process for producing l glutamic acid |
Also Published As
| Publication number | Publication date |
|---|---|
| KR910003108A (en) | 1991-02-26 |
| JPH0349690A (en) | 1991-03-04 |
| MY105945A (en) | 1995-02-28 |
| AU5874590A (en) | 1991-03-28 |
| JP2817228B2 (en) | 1998-10-30 |
| BR9003459A (en) | 1991-08-27 |
| KR970009156B1 (en) | 1997-06-07 |
| FR2649993A1 (en) | 1991-01-25 |
| PE33790A1 (en) | 1991-01-16 |
| FR2649993B1 (en) | 1993-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3707441A (en) | Method of producing l-lysine by fermentation | |
| JPS6236676B2 (en) | ||
| US5188948A (en) | Process for producing L-valine by fermentation | |
| US5492818A (en) | Method of producing L-glutamic acid by fermentation | |
| JPH02186995A (en) | Production of l-arginine by fermentation method | |
| JPS6321479B2 (en) | ||
| KR950005133B1 (en) | Method for preparing L-valine | |
| US4495283A (en) | Process for producing L-histidine by fermentation | |
| JP3046332B2 (en) | Production of amino acids by fermentation | |
| US5304476A (en) | Process for producing l-lysine by fermentation employing a microorganism resistant to acyl-lysine or methylated acyl-lysine | |
| US5272067A (en) | Process for producing L-glutamic acid | |
| JP3006929B2 (en) | Production method of L-valine by fermentation method | |
| AU628598B2 (en) | Process for producing l-glutamic acid | |
| US3763008A (en) | Process for producing ribosides of heterocyclic organic bases by fermentation | |
| US5188947A (en) | Process and microorganism for producing l-ornithine by corynebacterium, brevibacterium, or athrobacter | |
| JPH0632626B2 (en) | Fermentation method for producing L-threonine | |
| EP0287123B1 (en) | L-valine producing microorganism and a process for producing l-valine by fermentation | |
| US5302521A (en) | Process for producing L-lysine by iodothyronine resistant strains of Mucorynebacterium glutamicum | |
| JP2578474B2 (en) | Method for producing L-glutamic acid | |
| EP0567644B1 (en) | Process for producing l-alanine by fermentation | |
| EP0469517A2 (en) | Process for producing L-glutamic acid | |
| JP3006907B2 (en) | Method for producing L-alanine by fermentation method | |
| US5362636A (en) | Process for producing L-lysine by fermentation with a bacteria having selenalysine resistance | |
| US5478733A (en) | Process for producing L-alanine by fermentation with arthrobacter | |
| JPH055476B2 (en) |